Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Baxter International Inc BAX

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s Medical Products and Therapies segment includes sales of sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant and adhesion prevention products. Its Healthcare Systems and Technologies segment includes connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space, including surgical video technologies and precision positioning devices. Its Pharmaceuticals segment includes specialty injectable pharmaceuticals, inhaled anesthesia and drug compounding. Its Kidney Care segment includes chronic and acute dialysis therapies and services, including peritoneal dialysis, hemodialysis, continuous renal replacement therapies (CRRT) and other organ support therapies.


NYSE:BAX - Post by User

Post by ivosmithon Dec 15, 2023 3:22am
104 Views
Post# 35786095

Clinical Nutrition Market Report, Outlook 2023-2028

Clinical Nutrition Market Report, Outlook 2023-2028

According to the latest research report, the global clinical nutrition market size reached US$ 47.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 78.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.35% during 2023-2028.

The global clinical nutrition market is currently being primarily driven by the ongoing rise in the prevalence of metabolic disorders, increasing the risk of conditions such as obesity, high blood pressure, and abnormal cholesterol levels. Furthermore, the expanding geriatric population, which is more susceptible to chronic gastrointestinal ailments, is actively propelling the demand for clinical nutrition within the home healthcare model. In addition to this, the continuous increase in the number of preterm births, coupled with the growing need for clinical nutrition in the pediatric medicine segment, is further contributing to the ongoing growth of the market. Moreover, the continual upgrading of healthcare infrastructures and the implementation of government awareness programs regarding the easy accessibility of clinical nutrition procedures for disease management are currently acting as significant factors inducing growth.

Explore full report with Table of Contents: https://www.imarcgroup.com/clinical-nutrition-market

<< Previous
Bullboard Posts
Next >>